| 4OGI: reference: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology., Ciceri P, Muller S, O'Mahony A, Fedorov O, Filippakopoulos P, Hunt JP, Lasater EA, Pallares G, Picaud S, Wells C, Martin S, Wodicka LM, Shah NP, Treiber DK, Knapp S, Nat Chem Biol. 2014 Apr;10(4):305-12. doi: 10.1038/nchembio.1471. Epub 2014 Mar, 2. PMID: 24584101 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).